ArticleCureus2026
Application of a Cutting Guide to Optimize Fit of 3D-Printed Patient-Specific Implants in Reconstruction Following Resection of Osseo-Invasive Tumors.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In managing osseo-invasive tumors, such as meningiomas, the treatment of choice is complete resection, including the dural origin and any involved bone. Virtual preoperative surgical planning, combined with tailored intraoperative reconstruction, can optimize outcomes. Repairing bony defects with patient-specific implants (PSIs) in a single-stage procedure has been shown to reduce operative time and morbidity. Here, we present the use of a resection template to further optimize reconstruction outcomes. We analyzed five patients with cranial tumors exhibiting significant bony invasion who underwent surgery at our institution between June 2023 and January 2025. Tumor resection was virtually planned in collaboration with PSI manufacturers (Synthes
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.